Is the word 'biomarker' being properly used by proteomics research in neuroscience?

European Archives of Psychiatry and Clinical Neuroscience

Volumn 260, Issue 7, 2010, Pages 561-562

  Martins De Souza, Daniel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

LETTER; MEDICAL RESEARCH; NEUROSCIENCE; NOMENCLATURE; PRIORITY JOURNAL; PROTEOMICS; STANDARD;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; HUMANS; NEUROSCIENCES; PROTEOMICS; TERMINOLOGY AS TOPIC;

EID: 78549232985     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-010-0105-2     Document Type: Letter

References (2)

1. Chakravarty A (2003) Surrogate markers: their role in regulatory decision process. Food and Drug Administration, http://www.fda.gov/cder/Offices/ Biostatistics/Chakravarty-376/sld016.htm
2. H Mischak R Apweiler RE Banks, et al. 2007 Clinical proteomics: a need to define the field and to begin to set adequate standards Proteomics Clin Appl 1 148 156 1:CAS:528:DC%2BD2sXjtFCjsLY%3D 10.1002/prca.200600771